SK Life Science is a U.S. subsidiary of SK Biopharmaceuticals, focused on developing treatments for central nervous system (CNS) disorders and cancer. The company's work includes precision-guided approaches such as radiopharmaceutical therapy. It is based in Paramus, New Jersey.
The company has eight compounds under clinical development, targeting both CNS disorders and oncology. Its pipeline spans areas including radiopharmaceutical therapy and other precision-guided methodologies.
SK Life Science is part of the SK Group, a global conglomerate recognized by TIME as one of the World's Best Companies in 2024 and among its 100 Most Influential Companies in 2023. The company states its team of researchers, scientists, and professionals works collaboratively to develop products intended to make a meaningful impact on patients' lives.
